Alexander Wenk
Overview
Explore the profile of Alexander Wenk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
1320
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kreyling W, Holzwarth U, Hirn S, Schleh C, Wenk A, Schaffler M, et al.
Part Fibre Toxicol
. 2020 Jun;
17(1):21.
PMID: 32503677
Background: There is a steadily increasing quantity of silver nanoparticles (AgNP) produced for numerous industrial, medicinal and private purposes, leading to an increased risk of inhalation exposure for both professionals...
2.
Kreyling W, Holzwarth U, Schleh C, Hirn S, Wenk A, Schaffler M, et al.
Part Fibre Toxicol
. 2019 Jul;
16(1):29.
PMID: 31288843
Background: Industrially produced quantities of TiO nanoparticles are steadily rising, leading to an increasing risk of inhalation exposure for both professionals and consumers. Particle inhalation can result in inflammatory and...
3.
Kreyling W, Moller W, Holzwarth U, Hirn S, Wenk A, Schleh C, et al.
ACS Nano
. 2018 Aug;
12(8):7771-7790.
PMID: 30085651
The increasing use of gold nanoparticles leads to a possible increase of exposure by inhalation. Therefore, we have studied the deposition patterns of inhaled 20 nm gold nanoparticles (AuNP) in...
4.
Kreyling W, Holzwarth U, Haberl N, Kozempel J, Wenk A, Hirn S, et al.
Nanotoxicology
. 2017 Mar;
11(4):454-464.
PMID: 28290735
The biokinetics of a size-selected fraction (70 nm median size) of commercially available and V-radiolabeled [V]TiO nanoparticles has been investigated in healthy adult female Wistar-Kyoto rats at retention time-points of...
5.
Kreyling W, Holzwarth U, Schleh C, Kozempel J, Wenk A, Haberl N, et al.
Nanotoxicology
. 2017 Mar;
11(4):443-453.
PMID: 28290734
The biokinetics of a size-selected fraction (70 nm median size) of commercially available and V-radiolabeled [V]TiO nanoparticles has been investigated in female Wistar-Kyoto rats at retention timepoints 1 h, 4 ...
6.
Kreyling W, Holzwarth U, Haberl N, Kozempel J, Hirn S, Wenk A, et al.
Nanotoxicology
. 2017 Mar;
11(4):434-442.
PMID: 28290717
Submicrometer TiO particles, including nanoparticulate fractions, are used in an increasing variety of consumer products, as food additives and also drug delivery applications are envisaged. Beyond exposure of occupational groups,...
7.
Lipka J, Semmler-Behnke M, Wenk A, Burkhardt J, Aigner A, Kreyling W
Data Brief
. 2016 Oct;
7:1175-1178.
PMID: 27761500
Biokinetics data of lung-administered (1 h, 3 h, 8 h), to the P-radioactivity in the whole mouse body. Additionally, data was optimized to the available to the sum of all...
8.
Lipka J, Semmler-Behnke M, Wenk A, Burkhardt J, Aigner A, Kreyling W
Int J Pharm
. 2016 Jan;
500(1-2):227-35.
PMID: 26802492
Successful gene therapy requires stability and sufficient bioavailability of the applied drug at the site of action. In the case of RNA interference (RNAi), non-viral vectors play a promising role...
9.
Kreyling W, Abdelmonem A, Ali Z, Alves F, Geiser M, Haberl N, et al.
Nat Nanotechnol
. 2015 Jun;
10(7):619-23.
PMID: 26076469
Inorganic nanoparticles are frequently engineered with an organic surface coating to improve their physicochemical properties, and it is well known that their colloidal properties may change upon internalization by cells....
10.
Semmler-Behnke M, Lipka J, Wenk A, Hirn S, Schaffler M, Tian F, et al.
Part Fibre Toxicol
. 2015 May;
11:33.
PMID: 25928666
Background: There is evidence that nanoparticles (NP) cross epithelial and endothelial body barriers. We hypothesized that gold (Au) NP, once in the blood circulation of pregnant rats, will cross the...